Skip to content
Brand AI

Curia

Request correction

Corporate brand

Unclaimed

Curia is a global CDMO with over 30 years of experience in drug discovery, development, and manufacturing.

Last updated September 1, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Curia is a global contract research, development and manufacturing organization (CDMO) offering products and services across the drug development spectrum. It was founded in 1991 as Albany Molecular Research, Inc. (AMRI) and later renamed to AMRI, then to Curia. The company operates an integrated network of 20+ facilities and 3,000+ professionals across North America, Europe, and India.

History

Curia was founded in 1991 as Albany Molecular Research, Inc. (AMRI) by Thomas E. D’Ambra, Ph.D. In 1999, it became a publicly traded company on the NASDAQ. In 2007, it changed its name to AMRI. In April 2014, it acquired Cedarburg Pharmaceuticals, Inc., and in July 2014, it acquired Oso BioPharmaceuticals Manufacturing. The company is now known as Curia.

Recent events

  • Reported

    Curia agrees to acquire LakePharma[4]

    Curia announced that it had entered into an agreement to acquire LakePharma. The acquisition is expected to close later in 2021.

Read more

Sources4 sources

  1. 1Curia Global - Leading Global CDMOcuriaglobal.com
  2. 2About Us | Curiacuriaglobal.com
  3. 3Generic APIscuriaglobal.com
  4. 4Curia同意收购LakePharmawbjournal.com

Cite this profile: Cite the canonical profile. /brand-wiki/curia · Editorial policy · How profiles are compiled